NCT01507116 - Diabetes Attitudes Wishes and Needs | Biotech Hunter

Enrollment

8,985

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Relatives to/Carers of PatientsHealthcare Professionals

Interventions

OTHER

No treatment given

Three separate survey questionnaires, one for each of the three diabetes groups. Each questionnaire is composed of multiple items including pre-coded (multiple choice) questions, dichotomous (yes/no) questions and rating scales.

Trial Locations (17)

2300

Novo Nordisk Investigational Site, Copenhagen S

16035

Novo Nordisk Investigational Site, Algiers

28033

Novo Nordisk Investigational Site, Madrid

34335

Novo Nordisk Investigational Site, Istanbul

55127

Novo Nordisk Investigational Site, Mainz

92932

Novo Nordisk Investigational Site, Paris La Défense Cedex

100004

Novo Nordisk Investigational Site, Beijing

119330

Novo Nordisk Investigational Site, Moscow

560001

Novo Nordisk Investigational Site, Bangalore

1000005

Novo Nordisk Investigational Site, Tokyo

08540

Novo Nordisk Investigational Site, Princeton

L4W 4XI

Novo Nordisk Investigational Site, Mississauga

00144

Novo Nordisk Investigational Site, Rome

Unknown

Novo Nordisk Investigational Site, Mexico City

Novo Nordisk Investigational Site, Alphen aan den Rijn

PL-02-274

Novo Nordisk Investigational Site, Warsaw

RH11 9RT

Novo Nordisk Investigational Site, Crawley